Cargando…

γδ T Cells: The Ideal Tool for Cancer Immunotherapy

γδ T cells have recently gained considerable attention as an attractive tool for cancer adoptive immunotherapy due to their potent anti-tumor activity and unique role in immunosurveillance. The remarkable success of engineered T cells for the treatment of hematological malignancies has revolutionize...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yazdanifar, Mahboubeh, Barbarito, Giulia, Bertaina, Alice, Airoldi, Irma
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290982/ https://www.ncbi.nlm.nih.gov/pubmed/32456316 http://dx.doi.org/10.3390/cells9051305

Ejemplares similares

Engineering the Bridge between Innate and Adaptive Immunity for Cancer Immunotherapy: Focus on γδ T and NK Cells
por: Morandi, Fabio, et al.
Publicado: (2020)

Harnessing Mechanisms of Immune Tolerance to Improve Outcomes in Solid Organ Transplantation: A Review
por: Slepicka, Priscila Ferreira, et al.
Publicado: (2021)

The promise of γδ T cells and the γδ T cell receptor for cancer immunotherapy
por: Legut, Mateusz, et al.
Publicado: (2015)

γδ T cells in cancer immunotherapy
por: Zou, Chang, et al.
Publicado: (2016)

γδ T Cells and Their Potential for Immunotherapy
por: Wu, Yan-Ling, et al.
Publicado: (2014)

The emerging role of γδ T cells in cancer immunotherapy
por: Nussbaumer, Oliver, et al.
Publicado: (2019)

Interleukin-27 re-educates intratumoral myeloid cells and down-regulates stemness genes in non-small cell lung cancer
por: Airoldi, Irma, et al.
Publicado: (2015)

γδ T Cell Immunotherapy—A Review
por: Kobayashi, Hirohito, et al.
Publicado: (2015)

Human γδ T Cell Subsets and Their Clinical Applications for Cancer Immunotherapy
por: Lee, Derek, et al.
Publicado: (2022)

Monitoring Circulating γδ T Cells in Cancer Patients to Optimize γδ T Cell-Based Immunotherapy
por: Oberg, Hans-Heinrich, et al.
Publicado: (2014)

Cancer immunotherapy with γδ T cells: many paths ahead of us
por: Kabelitz, Dieter, et al.
Publicado: (2020)

Local γδ T cells: translating promise to practice in cancer immunotherapy
por: Zlatareva, Iva, et al.
Publicado: (2023)

γδ T cells for cancer immunotherapy: A systematic review of clinical trials
por: Fisher, Jonathan PH, et al.
Publicado: (2014)

Γδ T Cell-Based Immunotherapy in Melanoma: State of the Art
por: Toia, F., et al.
Publicado: (2019)

γδ T cells: origin and fate, subsets, diseases and immunotherapy
por: Hu, Yi, et al.
Publicado: (2023)

HLA-G and Other Immune Checkpoint Molecules as Targets for Novel Combined Immunotherapies
por: Morandi, Fabio, et al.
Publicado: (2022)

SNAI2/Slug gene is silenced in prostate cancer and regulates neuroendocrine differentiation, metastasis-suppressor and pluripotency gene expression
por: Esposito, Silvia, et al.
Publicado: (2015)

The Role of Human γδ T Cells in Anti-Tumor Immunity and Their Potential for Cancer Immunotherapy
por: Liu, Yuxia, et al.
Publicado: (2020)

Cancer Immunotherapy Using γδT Cells: Dealing with Diversity
por: Scheper, Wouter, et al.
Publicado: (2014)

Editorial: Next generation γδ T cell-based tumor immunotherapy
por: Tan, Andy Hee-Meng, et al.
Publicado: (2022)

γδ T cells in immunotherapies for B-cell malignancies
por: Rimailho, Léa, et al.
Publicado: (2023)

Strategies to Improve the Antitumor Effect of γδ T Cell Immunotherapy for Clinical Application
por: Miyashita, Masatsugu, et al.
Publicado: (2021)

3D modelling of γδ T‐cell immunotherapy
por: Hull, Caroline M., et al.
Publicado: (2022)

Potential Use of γδ T Cell-Based Vaccines in Cancer Immunotherapy
por: Khan, Mohd Wajid A., et al.
Publicado: (2014)

CAR‐NK cell in cancer immunotherapy; A promising frontier
por: Marofi, Faroogh, et al.
Publicado: (2021)

Characterization of Donor Variability for γδ T Cell ex vivo Expansion and Development of an Allogeneic γδ T Cell Immunotherapy
por: Burnham, Rebecca E., et al.
Publicado: (2020)

Multifunctional γδ T cells and their receptors for targeted anticancer immunotherapy
por: Scheper, Wouter, et al.
Publicado: (2013)

Immunotherapy of acute myeloid leukemia based on γδ T cells
por: Gertner-Dardenne, Julie, et al.
Publicado: (2012)

Current Advances in γδ T Cell-Based Tumor Immunotherapy
por: Lo Presti, Elena, et al.
Publicado: (2017)

γδ T Cells for Leukemia Immunotherapy: New and Expanding Trends
por: Barros, Mateus de Souza, et al.
Publicado: (2021)

A close look at current γδ T-cell immunotherapy
por: Ma, Ling, et al.
Publicado: (2023)

Biological characteristics of γδT cells and application in tumor immunotherapy
por: Zhu, Renhong, et al.
Publicado: (2023)

Correction to: Cancer immunotherapy with γδ T cells: many paths ahead of us
por: Kabelitz, Dieter, et al.
Publicado: (2020)

Targeting Cytokine Signals to Enhance γδT Cell-Based Cancer Immunotherapy
por: Song, Yuan, et al.
Publicado: (2022)

γδ T cells are effectors of immunotherapy in cancers with HLA class I defects
por: de Vries, Natasja L., et al.
Publicado: (2023)

Therapeutic avenues for γδ T cells in cancer
por: Costa, Gonçalo Palrão, et al.
Publicado: (2023)

Harnessing TRAIL-Induced Apoptosis Pathway for Cancer Immunotherapy and Associated Challenges
por: Razeghian, Ehsan, et al.
Publicado: (2021)

The Aging of γδ T Cells
por: Xu, Weili, et al.
Publicado: (2020)

Possibility of γδ T cell immunotherapy for HTLV-1-infected individuals
por: Sato, Tomoo, et al.
Publicado: (2011)

3D models for melanoma γδ T cell‐based immunotherapy
por: Huber, Veronica, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ela8q60qd627m0lr4hrmu894bh